BMC Plant Biology· 2026Q1
Integrated transcriptomic and WGCNA approaches identify a regulatory hub gene for flavonol glycoside biosynthesis in extreme chemotypes of Epimedium
- 1citations
- Q1SCImago
- 2026year
Short summary
A study of 5 Epimedium species with extreme flavonol glycoside accumulation identified five hub genes regulating biosynthesis, including a novel 2”-O-glycosyltransferase positively correlated with epimedin C and a rhamnosyltransferase linked to epimedin A, B, and icariin.
AI-generated from the title and abstract; the full text is not read.
Key points
- Identified five extreme chemotypes of Epimedium based on flavonol glycoside content using HPLC.
- Integrated RNA-seq and WGCNA to reveal five hub genes regulating flavonol glycoside biosynthesis.
- A novel 2”-O-glycosyltransferase positively correlates with epimedin C accumulation.
- A rhamnosyltransferase positively correlates with epimedin A, B, and icariin synthesis.
- Three MYB transcription factors negatively correlate with epimedin C synthesis.
AI-generated from the title and abstract; the full text is not read.
Abstract
Epimedium , a traditional Chinese medicinal herb belonging to the perennial Epimedium genus of the Berberidaceae family, has a documented medicinal history spanning over 2,000 years. However, reports on the regulatory mechanisms underlying the biosynthesis of its key flavonol glycosides (epimedin A, B, C, and icariin) remain scarce. This study employed High Performance Liquid Chromatography (HPLC) and RNA Sequencing (RNA-seq) strategies to elucidate the regulatory network governing flavonol glycoside synthesis in Epimedium . By conducting HPLC based quantification of flavonol glycosides in the leaves of 22 Epimedium species grown under identical environmental conditions, five species exhibiting extreme flavonol glycoside accumulation were identified. Based on their content profiles, the Epimedium accessions were classified into extremely high, inter-mediate, and extremely low groups. Interestingly, we found that an endangered Epimedium species ( Epimedium truncatum ) has a much higher content of epimedin C than other pharmacopoeial species, which may be the reason for its gradual disappearance. RNA-seq analysis of these five selected species, combined with Weighted Gene Co-expression Network Analysis (WGCNA), revealed five hub genes central to the regulation of flavonol glycoside synthesis, along with their associated interaction networks. Among these, the expression levels of three MYB-type transcription factors were negatively correlated with epimedin C synthesis. In contrast, the expression of a previously unreported 2”-O-glycosyltransferase showed a positive correlation with the accumulation of epimedin C, while the expression of a rhamnosyltransferase was positively correlated with the synthesis of epimedin A, B and icariin. We further validated the five hub genes in Epimedium using qPCR and quantified their expression levels across different medicinal parts. These findings suggest that these five genes can serve as marker genes indicative of flavonol glycoside content in Epimedium . In summary, this study integrates transcriptomic analysis of five Epimedium species with extreme chemotypes to unravel the intrinsic gene regulatory network underlying the biosynthesis of Epimedium flavonol glycosides, providing a foundation for chemotype-oriented breeding of Epimedium .
The authors' abstract, as published at the source. BMC Plant Biology, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Pharmacology (Pharmacology, Toxicology and Pharmaceutics)
PharmacologyPharmacology, Toxicology and Pharmaceutics